Randomised controlled trial of prolotherapy injections, saline injections and exercises in the treatment of chronic low back pain

Yelland, Michael John (2005). Randomised controlled trial of prolotherapy injections, saline injections and exercises in the treatment of chronic low back pain PhD Thesis, School of Population Health, The University of Queensland.

       
Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads
THE20977.pdf Full text application/pdf 9.05MB 2
Author Yelland, Michael John
Thesis Title Randomised controlled trial of prolotherapy injections, saline injections and exercises in the treatment of chronic low back pain
School, Centre or Institute School of Population Health
Institution The University of Queensland
Publication date 2005
Thesis type PhD Thesis
Supervisor Paul Glasziou
Nikolai Bogduk
Philip Schluter
Total pages 208
Language eng
Subjects 11 Medical and Health Sciences
Formatted abstract

Prolotherapy is a treatment that aims to strengthen weakened ligaments that are believed to be a common cause of chronic musculoskeletal pain. It involves the repeated injection of tender ligaments with an irritant solution that purportedly stimulates inflammation and subsequent strengthening of these ligaments. This then leads to a reduction in pain and disability. The prolotherapy protocol used for chronic low back pain in general practice in Australia uses a solution of 20% glucose and 0.2% lignocaine and is supplemented by flexion/extension exercises and vitamin and mineral tablets. This thesis reports on a randomised controlled trial designed to assess the efficacy, safety, costs and predictors of outcome of the glucose/lignocaine and exercise components of this prolotherapy protocol. 

 

One hundred and ten participants with non-specific low back pain of average 14 years duration were randomised to have repeated prolotherapy or normal saline injections into tender Jumbo-pelvic ligaments and also to perform either flexion/extension exercises or normal activity over six months. A blinded assessment of pain intensity (VAS) and disability scores (Roland-Morris) was made at 10 weeks, and four, six, 12 and 24 months. 

 

Follow-up was achieved in 96% of participants at 12 months and in 80% at 24 months. Ligament injections, with or without exercises, resulted in significant and sustained reductions in pain and disability throughout the 24 months of the trial, but no attributable effect was found for glucose/lignocaine solutions over saline solution nor for exercises over normal activity. The key summary results were the proportions at 12 months achieving >50% reduction in pain from baseline. By injection group, these were glucose-lignocaine, 0.46 versus saline, 0.36, and by activity group, these were exercise, 0.41 versus normal activity, 0.39. Corresponding proportions for >50% reduction in disability were glucose-lignocaine, 0.42 versus saline, 0.34; and exercise, 0.36 versus normal activity, 0.38. There were no between group differences in any of the above measures at 12 months or at 24 months. There was a high incidence of minor side effects with the prolotherapy protocol but no long-term sequelae attributable to this treatment. 

 

Predictors of a poorer response included smoking, high anxiety and depression levels and previous use of over four different treatments. 

 

The savings in the costs of back pain to the cohort as a whole were 13 times the costs of the treatment. At 12 months, hours lost from paid work due to back pain decreased from 9.3% to 1.9% of usual paid hours and hours lost from unpaid work decreased from 29.8% to 14.3% of usual unpaid hours. There was no increase in the number employed. 

 

The results suggest that in chronic non-specific low back pain, significant and sustained reductions in pain and disability occur with ligament injections, irrespective of the solution injected or the concurrent use of exercises. The results cast doubt on the purported mechanisms of action of prolotherapy. Its role in practice is where less invasive therapies have failed and the patient has been fully informed of the potential benefits and risks of prolotherapy. 

Keyword Backache -- Treatment

Document type: Thesis
Collection: UQ Theses (RHD) - UQ staff and students only
 
Citation counts: Google Scholar Search Google Scholar
Created: Tue, 19 Feb 2013, 11:22:27 EST by Mr Lachlan Wong on behalf of Scholarly Communication and Digitisation Service